These findings underscore the close interplay between hemolytic anemia and pulmonary vasculature remodeling and proliferation through TGF-β mediators and highlight the importance of identifying modifiers that may lead to targeted therapy of SCD complications in the future. Here, TGFB1 is linked to Schnyder corneal dystrophy.